Jozsef A. Szasz
Targu-mures, MS 540136, Romania
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Clinical Outcomes and Predictors of Response to Levodopa-Entacapone-Carbidopa Intestinal Gel in Advanced Parkinson's Disease: A Retrospective Cohort Study over a 4-Year Period.
Journal: Pharmaceutics
Published: March 13, 2026
Levodopa-entacapone-carbidopa intestinal gel in advanced Parkinson's disease: an analysis of interim data for Romanian patients enrolled in the ELEGANCE study.
Journal: Journal of neural transmission (Vienna, Austria : 1996)
Published: March 05, 2026
Long-Term Effectiveness and Safety of LCIG in Romania. 3-year Results from a Prospective, Observational Study (DUOGLOBE).
Journal: Neuropsychiatric disease and treatment
Published: November 27, 2025
Pharmacogenetics in advanced Parkinson's disease.
Journal: Journal of neural transmission (Vienna, Austria : 1996)
Published: August 08, 2025
Distribution of NECAB1-Positive Neurons in Normal and Epileptic Brain-Expression Changes in Temporal Lobe Epilepsy and Modulation by Levetiracetam and Brivaracetam.
Journal: International journal of molecular sciences
Published: April 07, 2025
Antidiabetic GLP-1 Receptor Agonists Have Neuroprotective Properties in Experimental Animal Models of Alzheimer's Disease.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 09, 2025
Target-Controlled Sedation with Propofol Infusion for PEG-J Placement in Advanced Parkinson's Disease: A Prospective Observational Study on Safety and Feasibility.
Journal: Life (Basel, Switzerland)
Published: January 31, 2025
Levodopa-Carbidopa Intestinal Gel Improves Dyskinesia in Parkinson's Disease: Post Hoc Analysis from the COSMOS Study.
Journal: Movement disorders clinical practice
Published: January 06, 2025
Levodopa-Entacapone-Carbidopa Intrajejunal Infusion in Advanced Parkinson's Disease - Interim Analysis of the ELEGANCE Study.
Journal: Movement disorders clinical practice
Published: December 05, 2024
Levodopa-Carbidopa-Entacapone Intestinal Gel in Advanced Parkinson Disease: A Multicenter Real-Life Experience.
Journal: American journal of therapeutics
Published: March 09, 2024
Levodopa-Entacapone-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson's Disease: A Single Center Real-World Experience.
Journal: Pharmaceutics
Published: January 19, 2024
Last Updated: 09/26/2026